Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Tang, G. Wells, M. Talajic, M. Arnold, R. Sheldon, S. Connolly, S. Hohnloser, G. Nichol, D. Birnie, J. Sapp, R. Yee, J. Healey, J. Rouleau (2010)
Cardiac-resynchronization therapy for mild-to-moderate heart failure.The New England journal of medicine, 363 25
G. Yao, N. Freemantle, M. Calvert, S. Bryan, J. Daubert, J. Cleland (2006)
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.European heart journal, 28 1
P. Vardas, A. Auricchio, J. Blanc, J. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. Morgado, A. Oto, R. Sutton, M. Trusz‐Gluza (2007)
Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 9 10
A. Feldman, G. Lissovoy, M. Bristow, L. Saxon, T. Marco, D. Kass, J. Boehmer, Steven Singh, D. Whellan, P. Carson, A. Boscoe, T. Baker, Matthew Gunderman (2005)
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.Journal of the American College of Cardiology, 46 12
C. Daubert, M. Gold, W. Abraham, S. Ghio, C. Hassager, G. Goode, T. Szili-Török, C. Linde (2009)
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.Journal of the American College of Cardiology, 54 20
P. Vardas, A. Auricchio, J. Blanc, J. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. Morgado, A. Oto, R. Sutton, M. Trusz‐Gluza (2007)
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.European heart journal, 28 18
P. Vardas, A. Auricchio, J. Blanc, J. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. Morgado, A. Oto, R. Sutton, M. Trusz‐Gluza, A. Vahanian, J. Camm, R. Caterina, V. Dean, K. Dickstein, C. Funck-Brentano, G. Filippatos, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. Zamorano, S. Priori, C. Blomström-Lundqvist, M. Brignole, J. Terradellas, Perez Castellano, J. Cleland, J. Farré, M. Fromer, J. Heuzey, G. Lip, J. Merino, A. Montenero, P. Ritter, M. Schalij, C. Stellbrink (2008)
[Guidelines for cardiac pacing and cardiac resynchronization therapy].Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 27 5
A. Barsheshet, A. Moss, M. Eldar, David Huang, W. Hall, H. Klein, S. McNitt, J. Steinberg, D. Wilber, W. Zareba, I. Goldenberg (2011)
Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction.European heart journal, 32 13
J. Cleland, J. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi (2005)
The effect of cardiac resynchronization on morbidity and mortality in heart failure.The New England journal of medicine, 352 15
F. Cuoco (2011)
Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) StudyYearbook of Cardiology, 2011
C. Linde, S. Mealing, N. Hawkins, J. Eaton, B. Brown, J. Daubert (2011)
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).European heart journal, 32 13
A. Moss, W. Hall, D. Cannom, H. Klein, Mary Brown, J. Daubert, N. Estes, E. Foster, H. Greenberg, S. Higgins, M. Pfeffer, S. Solomon, D. Wilber, W. Zareba (2009)
Cardiac-resynchronization therapy for the prevention of heart-failure events.The New England journal of medicine, 361 14
M. Gold (2012)
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)Yearbook of Cardiology, 2012
K. Dickstein, P. Vardas, A. Auricchio, J. Daubert, C. Linde, J. McMurray, P. Ponikowski, S. Priori, R. Sutton, D. Veldhuisen, A. Vahanian, Jeroen Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, Richard Hobbs, P. Kearney, T. McDonagh, B. Popescu, Željko Reiner, U. Sechtem, P. Sirnes, M. Tendera, P. Vardas, Petr Widimsky, S. Anker, J. Blanc, M. Gasparini, A. Hoes, Carsten Israel, Z. Kalarus, B. Merkely, K. Swedberg, A. Camm (2011)
2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure
M. Gold (2012)
Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRTYearbook of Cardiology, 2012
P. Vardas, D. Veldhuisen (2010)
Focused update of the ESC Guidelines on device therapy in heart failure.European heart journal, 31 21
M. Bristow, L. Saxon, J. Boehmer, S. Krueger, D. Kass, T. Marco, P. Carson, L. DiCarlo, D. DeMets, B. White, Dale Devries, A. Feldman (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.The New England journal of medicine, 350 21
TRIPLE EDITORIAL European Heart Journal (2011) 32, 1580–1582 doi:10.1093/eurheartj/ehr016 Cardiac resynchronization therapy: from treatment to prevention 1 2 Christophe Leclercq and Jagmeet P. Singh 1 2 CHU Rennes, Service de Cardiologie et Maladies Vasculaires, INSERM, CIC-IT, 35000 Rennes, France; and Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA Online publish-ahead-of-print 14 February 2011 This editorial refers to ‘Response to preventive cardiac As the patient population eligible for CRT continues to expand, resynchronization therapy in patients with ischaemic and together with the fact that a substantial proportion of patients nonischaemic cardiomyopathy in MADIT-CRT’ ,by remain non-responsive to CRT, it is imperative that we attempt A. Barsheshet et al., on page 1622, ‘Time-dependent to better define responders and non-responders to CRT, as well benefit of preventive cardiac resynchronization therapy as address the cost-effectiveness of this therapeutic intervention. after myocardial infarction’ , by A. Barsheshet et al.,on The results from the REVERSE, MADIT-CRT, and RAFT trials page 1614, and ‘Cost-effectiveness of cardiac resyncroniza- showed some uniformity in that a QRS duration of .150 ms 5,6 tion therapy in patients with asymptomatic to mild heart was predictive of a favourable response to CRT. The failure: insights from the European cohort
European Heart Journal – Oxford University Press
Published: Jul 14, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.